Is Vertex Stock Outperforming the Dow? [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
With a market cap of $122.7 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a leading biotechnology company focused on discovering, developing, and commercializing transformative medicines for serious diseases, particularly in areas of high unmet medical need. Founded in 1989 and headquartered in Boston, Massachusetts, Vertex is best known for building the first and dominant class of therapies that treat the underlying cause of cystic fibrosis (CF), establishing a durable global franchise with blockbuster drugs such as Trikafta/Kaftrio. Companies valued at $10 billion or more are generally considered "large-cap" stocks, and Vertex fits this criterion perfectly, exceeding the mark. More News from Barchart As Nvidia Launches New AI Laptop Chips, Should You Buy NVDA Stock? 3 Highest Rated Dividend Kings for Generations of Income GE Aerospace Is Linking Up with Palantir. Should You Buy GE Stock Here? Tired of missing midday reversals? The FREE Barchart Brief newsletter
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Crispr Therapeutics gains amid takeover speculation [Seeking Alpha]Seeking Alpha
- TIME Reveals 2026 Women of the Year List Recognizing 16 Leaders Working Toward a More Equitable World [Yahoo! Finance]Yahoo! Finance
- Physician-Scientist Reshma Kewalramani Runs One of Biotech's Biggest Companies [Yahoo! Finance]Yahoo! Finance
- Is Vertex Pharmaceuticals (VRTX) Now Offering A Compelling Entry Point After Flat One Year Returns [Yahoo! Finance]Yahoo! Finance
- Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade) [Seeking Alpha]Seeking Alpha
VRTX
Earnings
- 2/12/26 - Beat
VRTX
Sec Filings
- 2/27/26 - Form 144
- 2/27/26 - Form 144
- 2/26/26 - Form 4
- VRTX's page on the SEC website